US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Groupe Minoteries Sa (0QMM) 銘柄情報

Groupe Minoteries Sa (0QMM)

398.00

0.00

(0.00%)

終了 7月11日 12:30AM

Groupe Minoteries Sa (0QMM) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

398.00

( - )

買値

398.00

売値

398.00

出来高

0.00

平均取引量 (3 か月)

CHF 101

財務取引量

-

0.00 日の範囲 0.00

398.00 52 週間の範囲 398.00

時価総額

企業価値

88.313M

前日終値

398.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

151.86M

純利益

5.44M

発行済株式数

330,000

浮動株比率 (%)

95.09%

機関投資家保有比率 (%)

3.34%

配当利回り

11 (4.78%)

PER

14.31

株価売上高倍率 (PSR)

0.51

1 株当たり利益 (EPS)

16.49

ベータ

-

Groupe Minoteries SA engages in processing and marketing of food grains, plants, and raw materials in Switzerland. The company offers organic products, such as flours, organic mueslis, croissants, panettones, pizza, cereals, coatings, seeds, durum wheat, flakes, and extruded products, as well as bre... Groupe Minoteries SA engages in processing and marketing of food grains, plants, and raw materials in Switzerland. The company offers organic products, such as flours, organic mueslis, croissants, panettones, pizza, cereals, coatings, seeds, durum wheat, flakes, and extruded products, as well as breadcrumbs and panades; and tailor-made products. It also provides services for the industrial, retail, and wholesaler. The company was founded in 1885 and is headquartered in Granges-près-Marnand, Switzerland. 詳細を表示

セクター

Consumer Staples

業界

-

ウェブサイト

www.gmsa.ch

本社

Granges-près-marnand, Switzerland

設立

1885

Groupe Minoteries Sa is listed in the Consumer Staples sector of the ロンドン証券取引所 with ticker 0QMM. The last closing price for Groupe Minoteries was CHF398. Over the last year, Groupe Minoteries shares have traded in a share price range of CHF 398.00 to CHF 398.00.

Groupe Minoteries currently has 330,000 shares in issue. The market capitalisation of Groupe Minoteries is CHF131.34 million. Groupe Minoteries has a price to earnings ratio (PE ratio) of 14.31.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	398	398	398	3	398	DE
52	0	0	398	398	398	1	398	DE
156	0	0	398	398	398	0	398	DE
260	0	0	398	398	398	0	398	DE

0QMM - Frequently Asked Questions (FAQ)

What is the current Groupe Minoteries Sa share price?

The current share price of Groupe Minoteries Sa is CHF 398.00

How many Groupe Minoteries Sa shares are in issue?

Groupe Minoteries Sa has 330,000 shares in issue

What is the market cap of Groupe Minoteries Sa?

The market capitalisation of Groupe Minoteries Sa is CHF 131.34M

What is the 1 year trading range for Groupe Minoteries Sa share price?

Groupe Minoteries Sa has traded in the range of CHF 398.00 to CHF 398.00 during the past year

What is the PE ratio of Groupe Minoteries Sa?

The price to earnings ratio of Groupe Minoteries Sa is 14.31

What is the cash to sales ratio of Groupe Minoteries Sa?

The cash to sales ratio of Groupe Minoteries Sa is 0.51

What is the registered address of Groupe Minoteries Sa?

The registered address for Groupe Minoteries Sa is Route des Moulins 31, Granges-près-Marnand, Vaud, 1523

What is the Groupe Minoteries Sa website address?

The website address for Groupe Minoteries Sa is www.gmsa.ch

jjjjjjjj

jjjjjjjj 9分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 9分前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 29分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 31分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 41分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 50分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 57分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 57分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 59分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 1時間前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Genz2 1時間前

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 1時間前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 2時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 2時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 2時間前

Non-promotional information until there is a press release is a wise move.

Groupe Minoteries

Brazilian Critical Miner...

Jpmorgan Chase Financial...

3375% until 07/31/2030 3...

Wisdomtree Short Jpy Lon...

0.125% IDX-LKD GILT 2036

Global X Telemed & Digi ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。